Inscripta Is Reimagining What The Synthetic Biology Company Of The Future Will Be

Inscripta, a global leader in genome engineering, is reshaping the image of a synthetic biology company.

Biomanufacturing is set to transform many industries by making the products that the world needs in a cleaner, more efficient, and sustainable way. But there is not a single playbook on how to realize that vision. As the synthetic biology industry continues to assess different strategies for success and longevity, Inscripta is shifting its vision from being a technology provider to developing and commercializing bio-based products using a lean and efficient approach to biomanufacturing.